Cholangiocarcinoma (Bile Duct Cancer) Latest Advances

Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma: A Retrospective Registry-Based Study Using the Korean Organ Transplant Registry (KOTRY).

Journal: Annals of transplantation

Published: December 16, 2025

Recent advances in the treatment of FGFR-altered cholangiocarcinoma.

Journal: Expert opinion on pharmacotherapy

Published: December 15, 2025

ASO Visual Abstract: Reappraisal of the Clinical Utility of Hi-cut Pancreaticoduodenectomy for Widespread Distal Cholangiocarcinoma: A Less Invasive Alternative to Hepatopancreatoduodenectomy.

Journal: Annals of surgical oncology

Published: December 13, 2025

Diffuse intrahepatic cholangiocarcinoma with diverse imaging findings

Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology

Published: December 10, 2025

Giant Cell Tumor of Soft Tissue Involving the Common Hepatic Duct: A Case Report and Review of the Literature.

Journal: International journal of surgical pathology

Published: December 03, 2025

Serum Procalcitonin: A Novel Tumor Biomarker for Diagnosis and Follow-Up in Fibrolamellar Hepatocellular Carcinoma.

Journal: medRxiv : the preprint server for health sciences

Published: December 03, 2025

Laparoscopic Radical Resection for Hilar Cholangiocarcinoma with Portal Vein Invasions.

Journal: Journal of visualized experiments : JoVE

Published: December 01, 2025

Primary Well-Differentiated Neuroendocrine Tumor of the Common Hepatic Duct.

Journal: International journal of surgical pathology

Published: December 01, 2025

Rodent-specific induction of cholestasis and cholangioma through the reduction of bile salt export pump by bardoxolone methyl.

Journal: The Journal of toxicological sciences

Published: November 30, 2025

Advances in the treatment and prognosis of intrahepatic cholangiocarcinoma

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]

Published: November 26, 2025

Camrelizumab combined with tegafur gimeracil oteracil potassium (S-1) and nab-paclitaxel for the treatment of initially unresectable cholangiocarcinoma

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: November 25, 2025

Targeted therapy for biliary tract cancer: facts and fictions as well as demands and challenges.

Journal: Expert review of anticancer therapy

Published: November 25, 2025

Filters

Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma: A Retrospective Registry-Based Study Using the Korean Organ Transplant Registry (KOTRY).

Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma: A Retrospective Registry-Based Study Using the Korean Organ Transplant Registry (KOTRY).

Recent advances in the treatment of FGFR-altered cholangiocarcinoma.

Recent advances in the treatment of FGFR-altered cholangiocarcinoma.

ASO Visual Abstract: Reappraisal of the Clinical Utility of Hi-cut Pancreaticoduodenectomy for Widespread Distal Cholangiocarcinoma: A Less Invasive Alternative to Hepatopancreatoduodenectomy.

ASO Visual Abstract: Reappraisal of the Clinical Utility of Hi-cut Pancreaticoduodenectomy for Widespread Distal Cholangiocarcinoma: A Less Invasive Alternative to Hepatopancreatoduodenectomy.

Diffuse intrahepatic cholangiocarcinoma with diverse imaging findings

Diffuse intrahepatic cholangiocarcinoma with diverse imaging findings

Giant Cell Tumor of Soft Tissue Involving the Common Hepatic Duct: A Case Report and Review of the Literature.

Giant Cell Tumor of Soft Tissue Involving the Common Hepatic Duct: A Case Report and Review of the Literature.

Serum Procalcitonin: A Novel Tumor Biomarker for Diagnosis and Follow-Up in Fibrolamellar Hepatocellular Carcinoma.

Serum Procalcitonin: A Novel Tumor Biomarker for Diagnosis and Follow-Up in Fibrolamellar Hepatocellular Carcinoma.

Laparoscopic Radical Resection for Hilar Cholangiocarcinoma with Portal Vein Invasions.

Laparoscopic Radical Resection for Hilar Cholangiocarcinoma with Portal Vein Invasions.

Primary Well-Differentiated Neuroendocrine Tumor of the Common Hepatic Duct.

Primary Well-Differentiated Neuroendocrine Tumor of the Common Hepatic Duct.

Rodent-specific induction of cholestasis and cholangioma through the reduction of bile salt export pump by bardoxolone methyl.

Rodent-specific induction of cholestasis and cholangioma through the reduction of bile salt export pump by bardoxolone methyl.

Advances in the treatment and prognosis of intrahepatic cholangiocarcinoma

Advances in the treatment and prognosis of intrahepatic cholangiocarcinoma

Camrelizumab combined with tegafur gimeracil oteracil potassium (S-1) and nab-paclitaxel for the treatment of initially unresectable cholangiocarcinoma

Camrelizumab combined with tegafur gimeracil oteracil potassium (S-1) and nab-paclitaxel for the treatment of initially unresectable cholangiocarcinoma

Targeted therapy for biliary tract cancer: facts and fictions as well as demands and challenges.

Targeted therapy for biliary tract cancer: facts and fictions as well as demands and challenges.